Monocytes in Tumorigenesis and Tumor Immunotherapy

被引:19
|
作者
Chen, Xiaodie [1 ]
Li, Yunqing [1 ]
Xia, Houjun [1 ]
Chen, Youhai H. [1 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol, Fac Pharmaceut Sci, Ctr Canc Immunol, Shenzhen 518000, Peoples R China
基金
中国国家自然科学基金;
关键词
monocytes; tumorigenesis; tumor microenvironment; myeloid-derived suppressor cells; tumor associated macrophages; immunotherapy; SUPPRESSOR-CELLS; PANCREATIC-CANCER; MYELOID CELLS; MACROPHAGES; METASTASIS; RESPONSES; DIFFERENTIATION; ACCUMULATION; POLARIZATION; ACTIVATION;
D O I
10.3390/cells12131673
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Monocytes are highly plastic innate immune cells that display significant heterogeneity during homeostasis, inflammation, and tumorigenesis. Tumor-induced systemic and local microenvironmental changes influence the phenotype, differentiation, and distribution of monocytes. Meanwhile, monocytes and their related cell subsets perform an important regulatory role in the development of many cancers by affecting tumor growth or metastasis. Thanks to recent advances in single-cell technologies, the nature of monocyte heterogeneity and subset-specific functions have become increasingly clear, making it possible to systematically analyze subset-specific roles of monocytes in tumorigenesis. In this review, we discuss recent discoveries related to monocytes and tumorigenesis, and new strategies for tumor biomarker identification and anti-tumor immunotherapy.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy
    Curti, A
    Isidori, A
    Ferri, E
    Terragna, C
    Neyroz, P
    Cellini, C
    Ratta, M
    Baccarani, M
    Lemoli, RM
    LEUKEMIA & LYMPHOMA, 2004, 45 (07) : 1419 - 1428
  • [22] THE EFFECT OF IMMUNOTHERAPY ON INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR PRODUCTION OF MONOCYTES IN ASTHMATIC-CHILDREN
    WANG, JY
    LEI, HY
    HSIEH, KH
    JOURNAL OF ASTHMA, 1992, 29 (03) : 193 - 201
  • [23] EXPERIMENTAL STUDIES OF TUMOR IMMUNOTHERAPY .2. TUMOR IMMUNOTHERAPY FOLLOWING TUMOR EXTIRPATION
    HAYASHI, S
    ACTA MEDICA OKAYAMA, 1976, 30 (03) : 197 - 208
  • [24] Monocytes and tumor angiogenesis.
    De Palma, Michele
    Venneri, Mary Anna
    Galli, Rossella
    Pucci, Ferdinando
    Naldini, Luigi
    CANCER RESEARCH, 2006, 66 (08)
  • [25] Tumor antigen targets and tumor immunotherapy
    Mufson, RA
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 337 - 343
  • [26] Clinical scale Immunomagnetic selection of CD14+monocytes to generate dendritic cells (DC) for tumor immunotherapy.
    Bornhaeuser, M
    Babatz, J
    Rollig, C
    Moeneclay, G
    Miltenyi, S
    Schmitz, M
    Ehninger, G
    BLOOD, 2002, 100 (11) : 831A - 831A
  • [27] NEURAMINIDASE AND TUMOR IMMUNOTHERAPY
    SEDLACEK, HH
    SEILER, FR
    SCHWICK, HG
    KLINISCHE WOCHENSCHRIFT, 1977, 55 (05): : 199 - 214
  • [28] Tumor immunity and immunotherapy
    Boura, P
    Kountouras, J
    Lygidakis, NJ
    HEPATO-GASTROENTEROLOGY, 2001, 48 (40) : 1040 - 1044
  • [29] Tapping into tumor immunotherapy
    Natalie DeWitt
    Nature Biotechnology, 2000, 18 (5) : 481 - 481
  • [30] Tumor immunotherapy on the fly?
    不详
    IMMUNOLOGY TODAY, 1996, 17 (09): : 399 - 399